PGP and leukemia: This specific cell line created by inducing drug resistance in the K562 leukemia cell line by exposing it to the chemotherapeutic drug doxorubicin serves as a model for studying multidrug resistance mechanisms, particularly related to P-gp expression and regulation, regarding leukemia treatment.